Advertisement
Screener

CABALETTA BIO, INC. (CABA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

CABALETTA BIO, INC. Cash Flow Breakdown

Cash flow breakdown shows where CABALETTA BIO, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $131.08M went out.
  • Fiscal year ended 2025-12-31: from investing, $50.27M went out.
  • Fiscal year ended 2025-12-31: from financing, $100.35M came in.
  • Fiscal year ended 2025-12-31: change in cash, $80.98M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$131.08M-$50.27M$93.56M$6.79M*-$80.98M
2024-12-31-$88.22M$47.29M$0.00$11.68M*-$29.28M
2023-12-31-$53.55M-$22.45M$185.20M$2.43M*$111.63M
2022-12-31-$46.38M-$27.22M$32.85M-$40.62M
2021-12-31-$34.11M$6.00M$48.25M$650.00K*$20.79M
2020-12-31-$26.77M-$7.98M-$192.00K-$34.77M
2019-12-31-$16.05M-$693.00K$71.21M$48.71M*$103.19M
2018-12-31-$4.66M$37.68M*$33.02M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$41.51M*$0.00*$6.25M*$143.74M*
2026-03-31-$42.56M$50.96M$6.94M$18.33M*$33.65M
2025-12-31-$35.34M*$49.80M*$0.00*$8.33M*
2025-09-30-$34.51M*-$50.08M*$93.56M*-$94.36M*
2025-06-30-$30.43M*-$49.20M*$0.00*$93.37M*
2025-03-31-$30.80M-$785.00K$0.00-$552.00K*-$32.13M
2024-12-31-$23.12M*$12.12M*$0.00*$4.37M*
2024-09-30-$20.32M*$12.25M*$0.00*
2024-06-30-$20.79M*$23.73M*-$5.75M*
2024-03-31-$23.99M-$812.00K$5.75M$1.11M*-$17.95M
2023-12-31-$16.45M*$1.14M*$91.74M*$1.31M*
2023-09-30-$12.60M*-$65.00K*-$141.00K*
2023-06-30-$11.89M*-$48.14M*$93.84M*
2023-03-31-$12.61M$24.62M-$232.00K$12.24M
2022-12-31-$12.13M*-$316.00K*$32.85M*
2022-09-30-$9.91M*$23.91M*$0.00*
2022-06-30-$11.53M*-$898.00K*$0.00*
2022-03-31-$12.81M-$49.91M$0.00-$62.67M
2021-12-31-$10.52M*$849.00K*$13.54M*
2021-09-30-$8.34M*$1.77M*$24.88M*
2021-06-30-$6.58M*$1.03M*$7.67M*
2021-03-31-$8.67M$2.35M$2.17M-$4.15M
2020-12-31-$9.17M*$1.89M*-$1.00K*
2020-09-30-$5.02M*$1.47M*$0.00*
2020-06-30-$7.64M*-$11.12M*-$147.00K*
2020-03-31-$4.93M-$226.00K-$44.00K-$5.20M
2019-12-31-$7.88M*-$273.00K*$73.31M*
2019-09-30-$2.08M*-$40.00K*-$2.10M*
2019-06-30-$3.82M*-$200.00K*-$956.00K*
2019-03-31-$2.27M-$180.00K$49.66M*$47.22M
2018-12-31-$1.91M*$25.14M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
AGENUS INC (AGEN)United States$0.383B1.41
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02